Maximizing Combination Approaches to Transform Safety & Efficacy Profiles

Time: 11:00 am
day: Workshop B


Garnering excitement across the precision oncology field, combination-based approaches have proven to expand therapeutic efficacy and optimize treatment outcomes. It is no surprise that the radiopharmaceuticals space is following full steam ahead, as we see early clinical data and uncover more about the preclinical learnings in dual therapies.

Discover more on combinations:

  • Explore immune checkpoint modulators with radioligands
  • Utilize DNA repair inhibitors such as PARP, ATM/ATR and DNA methyltransferases
  • Review GPCR combinations
  • Understand challenges with increased complexity of treatment regimens